abrdn US Small Cap Equity Fund Institutional (GSCIX)
44.11
-0.21
(-0.47%)
USD |
Sep 10 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.95% | 350.05M | 0.74% | 47.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -59.12M | 21.68% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation by investing in diversified portfolio of equity securities issued by small capitalization U.S. companies. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Aberdeen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
42
-903.77M
Peer Group Low
1.008B
Peer Group High
1 Year
% Rank:
62
-59.12M
-7.517B
Peer Group Low
2.400B
Peer Group High
3 Months
% Rank:
41
-3.699B
Peer Group Low
554.06M
Peer Group High
3 Years
% Rank:
85
-4.784B
Peer Group Low
6.067B
Peer Group High
6 Months
% Rank:
57
-6.032B
Peer Group Low
844.76M
Peer Group High
5 Years
% Rank:
84
-7.910B
Peer Group Low
8.842B
Peer Group High
YTD
% Rank:
61
-8.773B
Peer Group Low
1.437B
Peer Group High
10 Years
% Rank:
71
-10.08B
Peer Group Low
28.39B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of September 10, 2025.
Asset Allocation
As of June 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.69% |
| Stock | 99.31% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| REV Group, Inc. | 3.53% | 62.69 | 0.85% |
| Q2 Holdings, Inc. | 3.34% | 82.14 | -2.39% |
| JFrog Ltd. | 3.00% | 49.64 | -0.62% |
| Enpro, Inc. | 2.98% | 221.27 | 2.11% |
| Donnelley Financial Solutions, Inc. | 2.95% | 54.06 | -3.00% |
| Wintrust Financial Corp. | 2.82% | 137.08 | -0.60% |
| Ligand Pharmaceuticals, Inc. | 2.76% | 166.42 | 0.61% |
| WSFS Financial Corp. | 2.57% | 56.30 | -1.16% |
| ANI Pharmaceuticals, Inc. | 2.55% | 97.45 | -1.03% |
| Brinker International, Inc. | 2.52% | 154.58 | -0.73% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.65% |
| Administration Fee | 187.7K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1.00M None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation by investing in diversified portfolio of equity securities issued by small capitalization U.S. companies. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Aberdeen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (9-9-25) | 0.05% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 27.72 |
| Weighted Average Price to Sales Ratio | 4.258 |
| Weighted Average Price to Book Ratio | 5.748 |
| Weighted Median ROE | 19.02% |
| Weighted Median ROA | 5.64% |
| ROI (TTM) | 8.24% |
| Return on Investment (TTM) | 8.24% |
| Earning Yield | 0.0541 |
| LT Debt / Shareholders Equity | 2.081 |
As of June 30, 2025
Growth Metrics
| EPS Growth (1Y) | 22.42% |
| EPS Growth (3Y) | 17.45% |
| EPS Growth (5Y) | 20.16% |
| Sales Growth (1Y) | 10.71% |
| Sales Growth (3Y) | 14.08% |
| Sales Growth (5Y) | 13.85% |
| Sales per Share Growth (1Y) | 7.69% |
| Sales per Share Growth (3Y) | 10.76% |
| Operating Cash Flow - Growth Ratge (3Y) | 21.52% |
As of June 30, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:GSCIX", "name") |
| Broad Asset Class: =YCI("M:GSCIX", "broad_asset_class") |
| Broad Category: =YCI("M:GSCIX", "broad_category_group") |
| Prospectus Objective: =YCI("M:GSCIX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |